Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Analyst Upgrade Ignites Duchenne's Muscular Dystrophy Research Firm's Shares

Solid Biosciences' shares are up by more than 40% today after Chardan Capital Markets upgraded the firm's shares from "neutral" to "buy" and raised its price target from $7.50 to $10.00/share. Duchenne muscular dystrophy (DMD) research firm Solid Biosciences ...
Streetwise Reports | August 20, 2019 |

Olympia Financial Group: With us, it's personal

Olympia Financial Group conducts most of its operations through Olympia Trust Company, providing trust and custodial services to investors in Canada’s private capital markets. The company serves clients from across Canada and is a significant player i...
Brieanna McCutcheon | December 12, 2022 |

Gold royalty stock might be better than an ETF

It doesn’t look like the economy is going to be stable any time soon. Unrest in Europe, looming U.S. deficit questions and poor unemployment are just some of the factors keeping the markets in a state of flux. As we’ve told you before, wat...
Justin Dove | October 28, 2012 |

Buzz on the Bullboards: The Fastest Moving Up & Comers

In recent days, weeks, even months, markets on both sides of the 49 th parallel have been erratic as volatility has returned with a vengeance. Investors continue to gather at Stockhouse. What is a buying opportunity for one investor is a "selling window" for another. ...
Stockhouse Editorial | September 29, 2021 |

Powering the Green Energy Revolution: Discovering New Nickel Deposits in Canada

Here’s a green energy, electric vehicle metals play worth getting to know… now. Metal Energy Corp. ( TSX-V.MERG , Forum ) is a high-potential exploration & development company focussed on high-quality nickel projects in Canada’s prolific ...
Dave Jackson | January 24, 2022 |

Texas Oil & Gas Company Benefits Already from Acquisition Synergies

The nature of the savings expected in 2019 post-acquisition and other current operational highlights are discussed in a Raymond James report. In a Feb. 20 research note, analyst John Freeman reported that Diamondback Energy Inc. (FANG:NASDAQ) had a strong Q4/18 despit...
Streetwise Reports | February 26, 2019 |

Silver Miner's 'Poor Q1/19 Results Drive Quick Management Action'

The company's first-quarter results and its reaction to them are outlined in a ROTH Capital Partners report. In a May 6 research note, analyst Joe Reagor reported that ROTH Capital Partners lowered its target price on Endeavour Silver Corp. (EDR:TSX; EXK:NY...
Streetwise Reports | May 13, 2019 |

Women's Wellness Device Developer Posts In-Line Quarter, Catalysts Looming

A review of this Colorado company's first numbers of the year was provided in a Ladenburg Thalmann report. In a May 13 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Viveve Medical Inc.'s (VIVE:NASDAQ) Q1/19 "reads fine." Q1/19 rev...
Streetwise Reports | May 16, 2019 |

Analyst: U.S. Miner's 'Nevada Guidance Lowered, Longer-Term Outlook Unclear'

The company's cost cutting efforts are addressed in a CIBC report. In a June 6 research note, CIBC analyst Cosmos Chiu reported that Hecla Mining Co. (HL:NYSE) lowered 2019 guidance for its Nevada assets "but offered few insights into a longer-term sol...
Streetwise Reports | June 14, 2019 |

Allakos Shares Double on AK002 Phase 2 Results and Earnings

Allakos Inc. shares are soaring today as the company reported Q2/19 earnings and announced positive results from its phase 2 study for its AK002 inhibitor used in the treatment of eosinophil and mast cell related diseases. Clinical stage biotech company Allak...
Streetwise Reports | August 7, 2019 |
1 2 3 4 5 6 7 8 9